Elevance Health announced on July 28, 2025, that Steve Collis, a global healthcare executive, will join the company’s board of directors, effective August 1. Mr. Collis will also serve on the board’s Audit and Finance Committees, enhancing the board’s industry expertise and financial oversight capabilities.
Mr. Collis currently serves as Executive Chairman of the Board of Cencora (formerly AmerisourceBergen), where he previously held the role of President and Chief Executive Officer for 13 years. During his tenure, he led Cencora through significant strategic transformation, expanding its global reach and deepening its capabilities across the pharmaceutical and healthcare supply chain.
His deep experience in healthcare operations and long-term value creation aligns with Elevance Health's strategic objectives. His appointment is part of the board’s ongoing commitment to refresh its membership in support of the company’s strategy and stakeholder needs.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.